TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

NCT04453345 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

T-LGL Leukemia
Clpd-Nk

Interventions

DRUG: thalidomide + prednisone + methotrexate

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]